1. Home
  2. OTLY vs TECX Comparison

OTLY vs TECX Comparison

Compare OTLY & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oatly Group AB

OTLY

Oatly Group AB

HOLD

Current Price

$11.29

Market Cap

394.1M

ML Signal

HOLD

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$24.27

Market Cap

393.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
OTLY
TECX
Founded
1994
2019
Country
Sweden
United States
Employees
N/A
51
Industry
Packaged Foods
Sector
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
394.1M
393.0M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
OTLY
TECX
Price
$11.29
$24.27
Analyst Decision
Buy
Strong Buy
Analyst Count
5
5
Target Price
$15.50
$80.40
AVG Volume (30 Days)
78.7K
522.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$6.52
N/A
Revenue Next Year
$5.68
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.25
$13.70
52 Week High
$18.84
$27.21

Technical Indicators

Market Signals
Indicator
OTLY
TECX
Relative Strength Index (RSI) 47.68 61.79
Support Level $10.25 $16.53
Resistance Level $12.29 $26.24
Average True Range (ATR) 0.73 1.94
MACD -0.03 0.17
Stochastic Oscillator 27.24 96.78

Price Performance

Historical Comparison
OTLY
TECX

About OTLY Oatly Group AB

Oatly Group AB is engaged in the food and drinks industry. Some of its products include Oat Drink, Chilled Oat Drink, Oatgurt, Creamy Oat, and Icecreams, among others. It caters to Sweden, Germany, the United Kingdom, Netherlands, North America, Finland, and Other markets. The company generates revenue from the EMEA, Americas, and Asia regions, with the majority of revenue generated from the EMEA region.

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

Share on Social Networks: